Health And Medicine

Molecule 147 neutralizes 95 percent of Dengue and Zika viruses, a promising direction for host-directed treatments and combination therapy. Read More

The latest Vanderbilt Child Health Poll finds that many Tennessee parents are worried about the mental health of their children during the COVID-19 pandemic, and more than 80 percent of parents had concerns about their children attending school remotely. Read More

Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences. Read More

Thanks to major funding from the National Institutes of Health (NIH), researchers at Vanderbilt University Medical Center have made major inroads in understanding how high-density lipoprotein (HDL), commonly known as good cholesterol, in some cases may... Read More

William Tansey and colleagues identified proteins that interact with the cancer drug target WDR5 and are important for cancer cell growth. Read More

Alexander Bick, MD, PhD, assistant professor of Medicine in the Division of Genetic Medicine at Vanderbilt University Medical Center, has been selected as the first VUMC Discovery Scholar in Health and Medicine. Read More

Discovering the mechanism behind cell behavior that is a hallmark of type 2 diabetes, Vanderbilt researchers move closer to treatments for the disease, which affects 34 million Americans. Read More

COVID-19 patients admitted to intensive care in the early months of the pandemic were subject to a significantly higher burden of delirium and coma than is typically found in patients with acute respiratory failure. Read More

In a large-scale study of electronic health records, Vanderbilt University Medical Center investigators have determined the prevalence of functional seizures and characterized comorbidities associated with them. Read More

Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated aging. Read More

Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients. Read More

Moderna, remdesivir, AstraZeneca. VUMC’s experts have played an integral role in the development of these marquee COVID-19 therapeutics behind the scenes.  Read More

The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential therapeutic advances. Read More

A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma. Read More

This spring in the U.S., there were widespread delays in elective health care procedures and screenings. Read More

In March, Vanderbilt University Medical Center leaders established a command center on campus to address the myriad issues that the Medical Center would face in the coming days, weeks and months as the COVID-19 pandemic encroached on Tennessee, then Nashville and finally on campus. Read More

Craig Lindsley, William K. Warren, Jr. Chair in Medicine and university professor of chemistry, pharmacology and biochemistry, has been named editor in chief of the "Journal of Medicinal Chemistry." His appointment will begin Jan. 1.  Read More

Chancellor Daniel Diermeier will host a special presentation with coronavirus expert Dr. Mark R. Denison on Monday, Dec. 14, from 11 a.m. to noon Central time. Denison’s presentation, “Preparing for the COVID-19 Pandemic ... for 36 Years,” will explore why COVID-19 emerged, his lab’s discoveries, and where we go from here. Read More

David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1. This follows the departure of John York, who was recently named chief science officer of California-based food technology startup Impossible Foods. Read More

Understanding the function of host cells when infected with SARS-CoV-2 may lead to host-directed antiviral therapeutics. Read More